Lamotrigine, >=98%, powder

Code: L3791-50MG D2-231

Biochem/physiol Actions

Anticonvulsant.

Features and Benefits

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-...


 Read more

Your Price
€685.30 50MG
€842.92 inc. VAT
REQUEST

Biochem/physiol Actions

Anticonvulsant.

Features and Benefits

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. L3791.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

Packaging

10, 50 mg in glass bottle

assay≥98%
colorwhite
formpowder
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)rat ... Scn2a1(24766), Scnn1a(25122)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
originatorGlaxoSmithKline
Quality Level200
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
solubilityDMSO: soluble 20 mg/mL at 60 °C, H2O: insoluble
storage temp.2-8°C
Cas Number84057-84-1
Hazard Class6.1
Un Number2811
Pack GroupIII
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.